Europe Pharmaceutical Drugs Market Size Share Trends Forecast 2027

1. EUROPE PHARMACEUTICAL DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Europe Pharmaceutical Drugs Market - Overview Europe Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over the Counter Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Nervous System, Genito-urinary, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and by Country/Region (Germany, France, U.K., Italy, Spain, Russia, The Netherlands, Poland, Switzerland, Sweden, and Rest of Europe) was estimated to be valued at US$ 219.9 billion in 2019, and is projected to exhibit a CAGR of 4.5% over the forecast period (2019 – 2027), as highlighted in a new report published by Coherent Market Insights. Patent Expiry of Leading Branded Products is Paving the Entry for Generics, which, in turn, is expected to propel growth of the Europe Pharmaceutical Drugs devices market The pharmaceutical drugs market is expected to witness significant growth in the near future, owing to patent expiry of major pharmaceutical products. Generic products are economically priced and provide better affordability. Large number of companies are introducing these products in the global market, thus contributing to the high volume of the sales. Therefore, this has created lucrative opportunities for market players in supplying low cost of the generic formulation of the drug. For instance, Cetuximab (Erbitux) is an epidermal growth factor receptor inhibitor indicated for treatment of metastatic colorectal cancer. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/europe- pharmaceutical-drugs-market-3541 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Furthermore, increasing mergers and acquisitions are expected to drive growth of the Europe Pharmaceutical Drugs devices market during the forecast period. For instance, in August 2018, Novo Nordisk completed acquisition of U.K. based diabetes drug manufacturers Ziylo. The acquisition is expected to increase Novo Nordisk's product portfolio for diabetes therapeutics. Browse 30 Market Data Tables and 38 Figures spread through 199 Pages and in-depth TOC on ‘Europe Pharmaceutical Drugs Market’- Europe Forecast to 2027, by Drug Type (Generic Drugs, and Branded Drugs), by Product Type (Prescription Drugs, and Over the Counter Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology , Anti-infective, Metabolic Disorder, Central Nervous System, Genito-urinary, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and by Country/Region (Germany, France, U.K., Italy, Spain, Russia, Netherlands, Poland, Switzerland, Sweden, and Rest of Europe) Increasing incidence of chronic diseases is expected to drive the market growth. For example, over the past few years there has been an increase in the number of individuals diagnosed with diabetes in Europe, which is expected to drive demand for branded and generic drugs. For instance, in 2019, according to the International Diabetes Federation reports, prevalence of diabetes in European is estimated to increase from 6.3% in 2019 to around 7.8% by 2045. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3541 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of the Negative Pressure Wound Therapy Market: The Europe Pharmaceutical Drugs market is expected to exhibit a CAGR of 4.5% over the forecast period, owing to increasing incidence of diseases, mergers & acquisitions expenditure, and product For instance, on January 2019, Takeda Pharmaceutical Company Limited acquired Shire plc. The acquisition is expected to increase Takeda market presence in Europe. Among drug type, the branded segment is expected to dominate the Europe Pharmaceutical Drugs market in 2018 owing to increasing prevalence of chronic diseases and increasing strategic collaboration. For instance, according to reports published by the World Health Organization in 2017, around 10% of men and nearly 9% of women in the age group of 25 years and above have diabetes. Among product type, prescription drugs segment is expected to exhibit higher CAGR during the forecast period owing to increasing strategic partnerships between manufactures to enhance their presence in the market. For instance, in December 2019, Pfizer Inc. and GlaxoSmithKline entered a strategic agreement to combine their consumer health care units to create a joint venture to increase focus towards prescription medications. Among application type, the oncology segment is expected to hold a dominant position in the Europe Pharmaceutical Drugs market in 2019, owing to increasing patient population.Therefore, increasing patient population is expected to drive demand for pharmaceutical drugs in Europe during the forecast period. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3541 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved